LCE 75

Generic Name: carbidopa/entacapone/levodopa

Pill imprint LCE 75 has been identified as Stalevo 75 18.75 mg / 200 mg / 75 mg.

Stalevo 75 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.

Stalevo 75 18.75 mg / 200 mg / 75 mg is not subject to the Controlled Substances Act.
See also related documents.

Stalevo 75 Images

Generic Name:
carbidopa/entacapone/levodopa
Imprint:
LCE 75
Strength:
18.75 mg / 200 mg / 75 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Inactive Ingredients:
corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0544

View Drug DetailsPrint Page

Advertisement

Stalevo 75 is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web2)